These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 13781777)

  • 1. [Clinical experiences with iproniazid and additional monoamine oxidase inhibitors with analogous effects].
    VOELKEL A
    Psychiatr Neurol (Basel); 1960 Jul; 140():83-8. PubMed ID: 13781777
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences in the 1 to 2 year treatment of chronic psychiatric patients with MAO inhibitors].
    WICKSTROM L
    Sven Lakartidn; 1961 Mar; 58():664-8. PubMed ID: 13785006
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical, electroencephalographic and psychometric research on iproniazid (marsilid) in depressive diseases].
    MARTINI F; ANGELER F; BIAGIOTTI F
    Riv Patol Nerv Ment; 1959; 80():370-1. PubMed ID: 14421822
    [No Abstract]   [Full Text] [Related]  

  • 4. An in vivo test for measuring monoamine oxidase inhibition in human subjects.
    RESNICK O; HAGOPIAN M; HOAGLAND H; FREEMAN H
    AMA Arch Gen Psychiatry; 1960 Apr; 2():459-61. PubMed ID: 14437446
    [No Abstract]   [Full Text] [Related]  

  • 5. [Our experiences with monoamine oxidase inhibiting substances].
    TAUBER CG
    Psychiatr Neurol (Basel); 1960 Jul; 140():148-51. PubMed ID: 13775480
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of psychic diseases with iproniazid (marsilid)].
    SCHAEPPERLE O
    Nervenarzt; 1959 Dec; 30():557-61. PubMed ID: 14442364
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trial treatment with Catran in chronic mental patients. Preliminary report].
    WICKSTROM L
    Sven Lakartidn; 1960 Nov; 57():3374-8. PubMed ID: 13785007
    [No Abstract]   [Full Text] [Related]  

  • 8. [On monoamine-oxidase inhibitors].
    KROEBER E
    Psychiatr Neurol (Basel); 1960 Jul; 140():92-6. PubMed ID: 13754442
    [No Abstract]   [Full Text] [Related]  

  • 9. Calming effect of the monoamine oxidase inhibitors.
    ARNOT R
    Dis Nerv Syst; 1960 Aug; 21():448. PubMed ID: 13794397
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative trial of four monoamine oxidase inhibitors on chronic depressives.
    BATES TJ; DOUGLAS AD
    J Ment Sci; 1961 May; 107():538-46. PubMed ID: 13687739
    [No Abstract]   [Full Text] [Related]  

  • 11. Nialamide in the private practice of psychiatry.
    KLINE NS
    Dis Nerv Syst; 1959 Oct; 20():482-8. PubMed ID: 14409888
    [No Abstract]   [Full Text] [Related]  

  • 12. [Iproniazid and other inhibitors of monoamine oxidase in the treatment of angina pectoris].
    ABAZA A; RUTLISBERGER PA
    Presse Med (1893); 1960 May; 68():1049-52. PubMed ID: 13791366
    [No Abstract]   [Full Text] [Related]  

  • 13. Twenty month study of iproniazid therapy.
    JOEL SW
    Dis Nerv Syst; 1959 Nov; 20():521-4. PubMed ID: 14407353
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of reserpine, iproniazid (marsilid), and triiodothyronine (trionine), and of reserpine alone.
    GALLAGHER WJ; SCHROEPPEL AB; PFEIFFER CC
    AMA Arch Gen Psychiatry; 1959 Aug; 1():215-22. PubMed ID: 13826091
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical effects of Marsilid and its EEG evaluation].
    KRONBERGEROVA J; JANIK A
    Act Nerv Super (Praha); 1962; 4():229. PubMed ID: 14459822
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical results of treatment with "IIH" in cases of essential and symptomatic depressive psychopathy and psychoses].
    BELUFFI M
    Gazz Med Ital; 1959 Aug; 118():307-14. PubMed ID: 13798674
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of marsilid in the treatment of mental disorders resistive to previous therapy.
    BREITNER C
    Ariz Med; 1959 Nov; 16():732-5. PubMed ID: 13804145
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of iproniazid treatment in chronic akinetic patients.
    BELISLE JA; TOWNLEY MC; KOZLOWSKI VL; MARTEL P
    Am J Psychiatry; 1958 Dec; 115(6):544-5. PubMed ID: 13595131
    [No Abstract]   [Full Text] [Related]  

  • 20. Tranylcypromine on fifty ambulatory psychiatric patients.
    DARLING HF
    Dis Nerv Syst; 1962 Feb; 23():91-2. PubMed ID: 13883578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.